Strand Therapeutics

About:

Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.

Website: https://www.strandtx.com/

Twitter/X: StrandTx

Top Investors: Creative Destruction Lab (CDL), National Cancer Institute, BeiGene, ANRI, Alexandria Real Estate Equities

Description:

Strand Therapeutics is a developer of a biotechnology platform intended to create gene therapies powered by synthetic biology.The company's offerings include immunotherapies to help cells produce target cancer-killing proteins during immunotherapy, enabling patients to improve their body's immune system to fight cancer.

Total Funding Amount:

$104M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2017-01-01

Contact Email:

contact(AT)strandtx.com

Founders:

Darrell Irvine, Jacob Becraft, Ron Weiss, Tasuku Kitada

Number of Employees:

101-250

Last Funding Date:

2022-11-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai